[Secondary prevention following myocardial infarct].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003645:Death, Sudden; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control / Q000534:rehabilitation*; D010974:Platelet Aggregation / Q000187:drug effects; D012008:Recurrence
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D001241:Aspirin
Sekundärprophylaxe nach Myokardinfarkt.